Diagnosis and management of involutional osteoporosis
- PMID: 21297728
- PMCID: PMC2383039
Diagnosis and management of involutional osteoporosis
Abstract
Of postmenopausal women, 20-30% will experience symptomatic involutional osteoporosis. Though the cause is still poorly defined, recent information gives the family physician several routes to treat effectively most patients who become symptomatic. Two other responsibilities exist, however: defining occult causes for the porotic process which may be of greater importance than the osteoporosis itself, and attempting to treat patients at risk for future osteoporosis prophylactically. The latter is a task where we have very effective modes of therapy, but we are only just beginning to develop means of defining that populace destined to suffer from future osteoporosis.
Similar articles
-
Vertebral fractures in steroid dependent asthma and involutional osteoporosis: a comparative study.Thorax. 1991 Nov;46(11):803-6. doi: 10.1136/thx.46.11.803. Thorax. 1991. PMID: 1771602 Free PMC article.
-
Management of postmenopausal osteoporosis and the prevention of fractures.Panminerva Med. 2014 Jun;56(2):115-31. Epub 2014 Jun 19. Panminerva Med. 2014. PMID: 24942322
-
[Zinc excretion in osteoporotic women].Orv Hetil. 1993 Apr 25;134(17):911-4. Orv Hetil. 1993. PMID: 8479735 Clinical Trial. Hungarian.
-
[Diagnosis and pharmacologic therapy of osteoporosis].Orv Hetil. 2003 Jul 13;144(28):1373-9. Orv Hetil. 2003. PMID: 12914121 Review. Hungarian.
-
Does estrogen adequately protect postmenopausal women against osteoporosis: an iconoclastic perspective.J Clin Endocrinol Metab. 1999 Jun;84(6):1872-4. doi: 10.1210/jcem.84.6.5731. J Clin Endocrinol Metab. 1999. PMID: 10372678 Review.
References
LinkOut - more resources
Full Text Sources